• About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
    • Understanding Your Echocardiogram Results
    • News & Insights
    • HVV US Patient Journey Report
  • Events
  • Advocacy
    • Patient Spotlight Series
    • Apply to Be a Patient Ambassador
    • Share Your Story
    • Become an Advocate
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.
Heart Valve Voice USHeart Valve Voice US
  • About Us
    • Leadership
    • Our Supporters
    • IRS Form 990
  • Resources for Your Journey
    • What Is Heart Valve Disease?
    • Understanding Your Echocardiogram Results
    • News & Insights
    • HVV US Patient Journey Report
  • Events
  • Advocacy
    • Patient Spotlight Series
    • Apply to Be a Patient Ambassador
    • Share Your Story
    • Become an Advocate
    • HVD Policy Task Force
    • #Ask4Echo Campaign
  • Join Our Community
    • Sign Up For Our Mailing List
    • My Valve. My Voice.

HVV US is advocating for patients with mitral valve disease. See our comments to CMS

Home Policy CenterHVV US is advocating for patients with mitral valve disease. See our comments to CMS

HVV US is advocating for patients with mitral valve disease. See our comments to CMS

August 7, 2020 Policy Center, Policy Statement


Telehealth offers significant advantages to patients of all types, including and especially older Americans with mobility and other age-associated health conditions. We believe telehealth is not a trend but an important tool to facilitate safe, convenient, efficient access for patients. The new minimum surgical procedure thresholds for both new and established TEER programs have no scientific basis, are anti-competitive, and only serve to limit patient access.
If the goals of simplified reporting, increased transparency, broader access, and greater utility cannot be accommodated through the current TVT Registry structure, then CMS should consider an alternative reporting mandate to a patient-centered registry.  

Read more on our comments below.  

HVVUS_TEER-Comment-1Download
Tags: CMSMitral Valve
Share
1

You also might be interested in

CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients

CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients

Mar 28, 2019

Washington, D.C., March 27, 2019 – Below is a statement issued on[...]

Heart Valve Voice US Responds to COVID-19 Pandemic

Jun 23, 2020

Heart Valve Voice US has been tracking the impact of[...]

CMS Decision on TAVR Puts Patients at the End of the Line

Jun 24, 2019

The Centers for Medicaid and Medicare Services today issued their[...]

Contact Us

Please contact us with any questions or to get involved.

Send Message
Join the My Valve My Voice patient community Download the app
Sign Up for Our Mailing List
  • facebook
  • x
  • linkedin

© · Heart Valve Voice

Terms of Use
Privacy Policy

Website Management provided by Genacom

Contact Info

  • Heart Valve Voice US
  • 100 M Street SE 600 Washington, DC 20003
  • info@heartvalvevoice-us.org
  • https://www.heartvalvevoice-us.org
Prev Next